pefloxacin and Experimental Lung Inflammation
pefloxacin has been researched along with Experimental Lung Inflammation in 12 studies
Research
Studies (12)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (50.00) | 18.7374 |
1990's | 5 (41.67) | 18.2507 |
2000's | 1 (8.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Iudin, SM; Lobuseva, AN | 1 |
Ma, L; Sun, C; Wu, J | 1 |
Byl, B; Jacobs, F; Thys, JP | 1 |
Catena, E; de Iola, G; Ginesu, F; Gori, M; Grassi, C; Lucchini, M; Mangiarotti, P; Micillo, E; Onoscuri, M; Orlandi, O | 1 |
Garvez, MD; Limson, BM; Peña, AC | 1 |
Beuscart, C; Drugeon, H; Leroy, O; Mouton, Y; Pappo, M | 2 |
Gordin, FM; Hackbarth, CJ; Sande, MA; Scott, KG | 1 |
Fourrier, F; Gouin, F; Junginger, W; Martin, C; Prieur, BL | 1 |
Lauwers, S; Naessens, A; Pierard, D; Vincken, W | 1 |
Bouletreau, P; Chomarat, M; Flandrois, JP; Fournier, G; Joulie, V | 1 |
Aoun, M; Bourguignon, AM; Daneau, D; Janssen, M; Meunier, F; Van der Auwera, P; Varthalitis, I | 1 |
Reviews
1 review(s) available for pefloxacin and Experimental Lung Inflammation
Article | Year |
---|---|
Role of quinolones in the treatment of bronchopulmonary infections, particularly pneumococcal and community-acquired pneumonia.
Topics: Anti-Infective Agents; Bronchitis; Ciprofloxacin; Drug Therapy, Combination; Enoxacin; Humans; Ofloxacin; Pefloxacin; Pneumonia; Pneumonia, Pneumococcal | 1991 |
Trials
6 trial(s) available for pefloxacin and Experimental Lung Inflammation
Article | Year |
---|---|
Role of quinolones in the treatment of bronchopulmonary infections, particularly pneumococcal and community-acquired pneumonia.
Topics: Anti-Infective Agents; Bronchitis; Ciprofloxacin; Drug Therapy, Combination; Enoxacin; Humans; Ofloxacin; Pefloxacin; Pneumonia; Pneumonia, Pneumococcal | 1991 |
Pefloxacin in lower respiratory tract infections.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Bronchitis; Bronchopneumonia; Chronic Disease; Female; Humans; Injections, Intravenous; Male; Middle Aged; Pefloxacin; Pleurisy; Pneumonia | 1990 |
Monotherapy with pefloxacin in multidrug-resistant nosocomial gram-negative bacteraemia.
Topics: Administration, Oral; Adult; Aged; Cross Infection; Drug Resistance, Microbial; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Pefloxacin; Pneumonia; Pseudomonas Infections; Sepsis | 1990 |
[Prospective randomized controlled study of a ceftazidime and pefloxacin combination versus a ceftazidime and amikacin combination in the empirical treatment of pneumonia and nosocomial septicemia at intensive care units].
Topics: Amikacin; Ceftazidime; Cross Infection; Drug Therapy, Combination; Female; Humans; Intensive Care Units; Male; Middle Aged; Multicenter Studies as Topic; Pefloxacin; Pneumonia; Prospective Studies; Random Allocation; Sepsis | 1989 |
[Controlled randomized prospective study of a ceftazidime-pefloxacin combination versus a ceftazidime-amikacin combination in the empirical treatment of nosocomial pneumonias and septicemias of resuscitation. Preliminary results].
Topics: Amikacin; Bacterial Infections; Ceftazidime; Clinical Trials as Topic; Cross Infection; Drug Therapy, Combination; Female; Humans; Male; Pefloxacin; Pneumonia; Prospective Studies; Random Allocation | 1988 |
A prospective, randomized study of pefloxacin versus teicoplanin in the treatment of gram-positive coccal infections in cancer patients: early termination due to emergence of resistance to fluoroquinolones.
Topics: 4-Quinolones; Adult; Aged; Anti-Infective Agents; Bacteremia; Drug Resistance, Microbial; Drug Tolerance; Female; Fluoroquinolones; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Neoplasms; Pefloxacin; Pneumonia; Prospective Studies; Quinolones; Staphylococcal Infections; Teicoplanin | 1994 |
Other Studies
6 other study(ies) available for pefloxacin and Experimental Lung Inflammation
Article | Year |
---|---|
[Chemotherapeutic effectiveness of pefloxacin in experimental infections].
Topics: Acute Disease; Administration, Oral; Animals; Disease Models, Animal; Gram-Negative Bacteria; Gram-Positive Bacteria; Mice; Pefloxacin; Peritonitis; Pneumonia; Sepsis | 1994 |
[Study of pefloxacin concentration in blood and sputum in the aged pneumonia patients with impairment of renal function].
Topics: Aged; Anti-Infective Agents; Dose-Response Relationship, Drug; Female; Humans; Kidney; Male; Pefloxacin; Pneumonia; Renal Insufficiency; Sputum; Treatment Outcome | 2001 |
Activities of pefloxacin and ciprofloxacin in experimentally induced Pseudomonas pneumonia in neutropenic guinea pigs.
Topics: Agranulocytosis; Animals; Anti-Bacterial Agents; Ciprofloxacin; Guinea Pigs; Half-Life; Microbial Sensitivity Tests; Nalidixic Acid; Neutropenia; Pefloxacin; Pneumonia; Pseudomonas Infections; Quinolines; Time Factors | 1985 |
Pefloxacin in the treatment of nosocomial lower respiratory tract infections in intensive care patients.
Topics: Adolescent; Adult; Aged; Bronchopneumonia; Cross Infection; Female; Humans; Lung Abscess; Male; Middle Aged; Norfloxacin; Pefloxacin; Pneumonia; Prospective Studies; Respiration, Artificial | 1988 |
Efficacy and safety of pefloxacin in the treatment of severe infections in patients hospitalized in intensive care units.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bronchopneumonia; Cholangitis; Drug Evaluation; Female; Humans; Intensive Care Units; Male; Middle Aged; Norfloxacin; Pefloxacin; Pneumonia | 1986 |
[Pharmacokinetic study of pefloxacin in 37 hospital patients under resuscitation].
Topics: Humans; Intensive Care Units; Kinetics; Meningitis; Norfloxacin; Pefloxacin; Pneumonia; Risk; Sepsis | 1985 |